NCT07473843Phase 3Not yet recruiting
Study of Zodasiran in Adolescent Participants With Homozygous Familial Hypercholesterolemia
Study sponsor: Arrowhead Pharmaceuticals
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2028-07Estimated
Enrollment · participants12Estimated
Source updated2026-05-29Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.